(Q51620127)
Statements
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. (English)
1 reference
D R Matthews
1 reference
J P Hosker
1 reference
A S Rudenski
1 reference
M A Burnett
1 reference
R C Turner
1 reference
1 August 1989
1 reference
38
1 reference
8
1 reference
767-772
1 reference